Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Annovis Bio Inc

ANVS
28,23
0,00 (0,00%)
06 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/11/202414:00GLOBEAnnovis to Host Year-End Investor Webcast on December 11,..
12/11/202414:00GLOBEAnnovis Invited to Present at National Institute on Aging..
11/11/202414:00GLOBEAnnovis Bio Reports Third Quarter Financial Results and..
07/11/202414:00GLOBEAnnovis Bio Appoints Matthew Peterson, Ph.D., as Senior..
22/10/202414:00GLOBEAnnovis to Highlight Buntanetap's Alzheimer's Research..
15/10/202414:00GLOBEFDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s..
03/10/202414:30GLOBEAnnovis Bio Inc. (NYSE: ANVS) Leading Way in Development of..
02/10/202414:30GLOBEAnnovis Bio Inc. (NYSE: ANVS) Research Points to Potential..
30/9/202414:00GLOBEAnnovis Files Three New Patents for Combination Therapies..
05/9/202414:00GLOBEAnnovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th..
15/8/202413:00GLOBEAnnovis Bio Reports Second Quarter Financial Results and..
06/8/202414:00GLOBEAnnovis’ Lead Compound Enhances Cognition Synergistically..
24/7/202414:00GLOBEAnnovis Bio Secures U.S. Patent for Treatment of Acute..
16/7/202414:00GLOBEAnnovis Bio Receives FDA Approval to Transition to New..
09/7/202414:00GLOBEAnnovis Bio Welcomes Four New Executives to Strengthen..
02/7/202414:00GLOBEAnnovis Bio Announces New Data from Phase III Parkinson’s..
27/6/202414:00GLOBEAnnovis Bio Files Provisional Patent for New Manufacturing..
26/6/202414:00GLOBEAnnovis Bio Files Patent for New Composition of Matter for..
25/6/202414:00GLOBEAnnovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to..
18/6/202414:00GLOBEAnnovis Bio Highlights New Alzheimer’s Data at the..
11/6/202414:00GLOBEAnnovis Bio’s Buntanetap Found Safe and Effective in..
05/6/202414:00GLOBEAnnovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast
01/4/202414:00GLOBEAnnovis Announces Publication That Supports Understanding of..
20/3/202412:30GLOBEAnnovis Bio Provides Data Announcement Update for the Phase..
27/2/202414:00GLOBEAnnovis Bio Announces Participation in Forum Discussion at..
14/2/202413:30GLOBEAnnovis Bio Announces Last Patient Last Visit in the Phase..
30/1/202414:00GLOBEAnnovis Bio Announces the Filing of New Patent Application..
24/1/202414:00GLOBEAnnovis Bio Refines Timeline for Parkinson’s Phase III Study..
Apertura: Min: Max:
Chiusura: 28,23

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network